EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE
IMAM, N., . ZALAT, R., NEGM, M., BOCKTOR, N. (2022). EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE. EKB Journal Management System, 52(2), 183-192. doi: 10.21608/jesp.2022.257331
NAGLAA F. A. IMAM; RABAB S . ZALAT; MOHAMED SHERIF NEGM; NARDEEN ZAKKA BOCKTOR. "EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE". EKB Journal Management System, 52, 2, 2022, 183-192. doi: 10.21608/jesp.2022.257331
IMAM, N., . ZALAT, R., NEGM, M., BOCKTOR, N. (2022). 'EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE', EKB Journal Management System, 52(2), pp. 183-192. doi: 10.21608/jesp.2022.257331
IMAM, N., . ZALAT, R., NEGM, M., BOCKTOR, N. EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE. EKB Journal Management System, 2022; 52(2): 183-192. doi: 10.21608/jesp.2022.257331